Cite
HARVARD Citation
Nadkarni, G. et al. (n.d.). Trimetazidine Decreases Risk of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease. Journal of cardiovascular pharmacology and therapeutics. pp. 539-546. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nadkarni, G. et al. (n.d.). Trimetazidine Decreases Risk of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease. Journal of cardiovascular pharmacology and therapeutics. pp. 539-546. [Online].